Hologic Showcases New Genius AI Powered Imaging Technology for Breast Health Care
|
By MedImaging International staff writers Posted on 04 Mar 2021 |
|
Illustration
Hologic, Inc. (Marlborough, MA, USA) showcased its latest innovations at the fully virtual ECR 2021, including the new Genius AI™ powered imaging technology for sharper, faster and smarter detection and diagnosis in breast health care.
The ECR is the second-largest radiological meeting in the world with attendees spanning all areas of the radiology arena, including radiology professionals, radiographers, physicists, and industry representatives. At the 2021 edition of ECR held in Vienna, Austria from March 3-10, 2021, Hologic showcased its Genius AI™ Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
The new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam. The new technology highlights areas with subtle potential cancers that can be difficult to detect for further examination by the radiologist, and is designed to provide higher sensitivity and a false-positive rate much lower than Hologic’s previous generation CAD products.
The new software delivers key metrics at the time of image acquisition to help radiologists categorize and prioritize cases by complexity and expected read time in order to optimize workflow and expedite patient care. It is the only deep learning product on the market that runs on the acquisition workstation of the mammography system without the need for a separate server, providing a simple, convenient and secure environment.
The Genius AI Detection software is the only 3D CAD solution that supports Hologic’s latest innovations in tomosynthesis imaging, Clarity HD™ and 3DQuorum™ imaging technology, in addition to standard-resolution tomosynthesis. The Genius® 3D Mammography™ exam is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius exam is only available on the Hologic® 3D Mammography™ system.
Related Links:
Hologic, Inc.
The ECR is the second-largest radiological meeting in the world with attendees spanning all areas of the radiology arena, including radiology professionals, radiographers, physicists, and industry representatives. At the 2021 edition of ECR held in Vienna, Austria from March 3-10, 2021, Hologic showcased its Genius AI™ Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
The new technology represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam. The new technology highlights areas with subtle potential cancers that can be difficult to detect for further examination by the radiologist, and is designed to provide higher sensitivity and a false-positive rate much lower than Hologic’s previous generation CAD products.
The new software delivers key metrics at the time of image acquisition to help radiologists categorize and prioritize cases by complexity and expected read time in order to optimize workflow and expedite patient care. It is the only deep learning product on the market that runs on the acquisition workstation of the mammography system without the need for a separate server, providing a simple, convenient and secure environment.
The Genius AI Detection software is the only 3D CAD solution that supports Hologic’s latest innovations in tomosynthesis imaging, Clarity HD™ and 3DQuorum™ imaging technology, in addition to standard-resolution tomosynthesis. The Genius® 3D Mammography™ exam is acquired on the Hologic® 3D Mammography™ system and consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set. The Genius exam is only available on the Hologic® 3D Mammography™ system.
Related Links:
Hologic, Inc.
Portable X-ray Unit
AJEX140H
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Mobile X-Ray System
K4W
Ultrasound Table
Women’s Ultrasound EA Table
Latest ECR 2021 News
- GE Healthcare Showcases Innovative AI, Digital and Imaging Solutions at ECR 2021
- Hitachi Unveils MRI Systems with Human-Centered Design at ECR 2021
- Mindray Showcases Advanced Imaging and Laboratory Diagnostic Solutions at ECR 2021
- Vieworks Presents Next Generation Photon-Understanding Detector Solution Powered by AI
- First Ever Autonomous AI Medical Imaging Application Previewed at ECR 2021
- VUNO Presents State-of-the-Art AI Medical Imaging Technology at ECR 2021
- Agfa Launches Groundbreaking SmartXR Artificial Intelligence on Its Mobile DR 100s
- Canon Demonstrates How AI Can Help to Drive Workflow in COVID-19 Era
- Shimadzu Showcases Latest Lab and Imaging Technologies at ECR 2021
- Carestream Showcases New Glass-Free Detector and Intelligent Solutions for Digital Radiography at Virtual ECR 2021
- Siemens Holds Live Demonstrations of Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy
- Philips Spotlights New and Enhanced Diagnostic and AI-Enabled Solutions to Streamline Workflows Across Imaging Enterprise
- Konica Minolta Launches New Solutions in Healthcare IT, X-Ray and Ultrasound Imaging at ECR 2021
- ECR 2021 Virtual Exhibition Features One of the Biggest-Ever Online Programs in Radiology
Channels
Radiography
view channel
AI Tool Predicts Five-Year Breast Cancer Risk from Mammograms
Breast cancer risk assessment during routine screening is difficult because many women who develop the disease have no known genetic mutations or family history. Static risk tools provide limited discrimination... Read more
AI Mammography Tools Detect Early Breast Cancer Signs Years Before Diagnosis
Breast cancer screening aims to detect tumors before symptoms develop, but subtle mammographic changes can appear years before diagnosis and may be missed during routine reads. Delayed detection can lead... Read more
MRI
view channel
Advanced MRI Reveals Structural Brain Changes Linked to Better Cognitive Health
Objective, noninvasive measures that capture subtle, training-related changes in adult brain structure remain limited in routine clinical practice. Quantifying neuroplasticity with precision is especially... Read more
Cardiac MRI Detects Hidden Heart Dysfunction After Heart Attack
Myocardial infarction often leaves patients with persistent ventricular dysfunction that can progress without obvious signs. Detecting early decline remains difficult because standard measures may miss... Read more
Ultrasound
view channel
Simple 2D Ultrasound Tool Accurately Estimates Placental Volume
Stillbirth remains a major cause of perinatal loss, with about 21,000 cases annually in the United States. Although placental abnormalities are linked to adverse pregnancy outcomes, routine monitoring... Read more
Portable 3D Ultrasound System Enables Reproducible Breast Cancer Monitoring
Breast cancer can develop between annual mammograms, and these interval cancers account for 20% to 30% of cases and tend to be more aggressive. The challenge is pronounced in people with dense breast tissue.... Read more
Nuclear Medicine
view channel
Radiotherapy Professionals Embrace AI as a Clinical Support Tool
Radiotherapy planning requires precise identification of organs at risk near a tumor, but manual contouring is repetitive and time-consuming, often delaying plan completion and straining specialist capacity.... Read more
Second PSMA PET Identifies Disease in More Than Half of Negative Cases
Biochemical recurrence of prostate cancer after prostatectomy or radiation can be difficult to localize when imaging is negative. Uncertain disease sites may delay salvage therapy and expose patients to... Read more
![Image: (A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within 7 days. (D) Multimodal imaging evaluation of patient 3, including X-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT. (Photo courtesy of SNMMI)](https://globetechcdn.com/mobile_medicalimaging/images/stories/articles/article_images/2026-06-07/294811110_image_1.jpg "Image: (A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within 7 days. (D) Multimodal imaging evaluation of patient 3, including X-ray, MRI (T2-weighted imaging, T2WI), CT, and B7-H3 PET/CT. (Photo courtesy of SNMMI)")
General/Advanced Imaging
view channel
New PE-RADS Framework Standardizes Pulmonary Embolism Imaging Reports
Pulmonary embolism is a sudden blockage of the lung’s blood vessels that reduces pulmonary blood flow, can strain the right hear,t and may be fatal if untreated. Patients often present with shortness of... Read more
Virtual Staining Technique Creates Histology Images from CT Data
Pulmonary hypertension, a disorder marked by pathological remodeling of the pulmonary vessels, often requires detailed histologic assessment. Yet routine pathology remains anchored in labor‑intensive,... Read more
CT-Derived Biomarker Predicts Outcomes in Gastric Cancer
Gastric cancer, also known as stomach cancer, is the fifth most common malignancy worldwide and often shows heterogeneous outcomes even within the same stage. Prognostic estimates typically rely on tumor-centric... Read more
AI Tool Enhances Response Assessment and Survival Prediction in Pleural Mesothelioma
Pleural mesothelioma, a cancer that grows as a thin, irregular layer along the lung wall, is difficult to measure on imaging. Clinicians rely on diameter-based Response Evaluation Criteria in Solid Tumors... Read moreImaging IT
view channel
Ambient AI Reporting Platform Streamlines Radiology Reporting
Radiology departments face growing imaging volumes and staffing shortages, creating reporting bottlenecks and pressure to maintain turnaround times. Conventional dictation tools document findings after... Read more
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
Industry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more
